We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




New Testing Method Simplifies Tuberculosis Diagnosis

By LabMedica International staff writers
Posted on 14 Oct 2022

In 2020 alone, tuberculosis (TB) killed 1. More...

5 million people worldwide, surpassed in lethality only by COVID-19. Both diseases spread readily through the air. The United Nations aims to end the TB epidemic by 2030. But with 10 million people newly infected just in 2020, meeting that goal will require aggressive efforts at early detection. For many years, TB detection has required a sputum sample. In fact, tuberculosis researchers and clinicians have long been taught not to accept samples that look like saliva. That’s because saliva might not contain enough bacteria to show up under the microscope or grow in culture. Even with a good sputum sample, though, traditional diagnostic techniques can miss a lot of cases. And there are other downsides to sputum. Coughing it up risks infecting people nearby, including medical providers. And some people can’t produce sputum on demand, while others feel stigmatized by the request. Now, in a promising new study, a multinational team of researchers may have found another way to identify the bacterial disease. Having patients spit into a cup, then loading saliva into a commercially available testing cartridge can detect the bacteria that causes TB, they found - even though the cartridge is designed to use sputum. If additional studies confirm the cartridges can reliably use saliva, the novel process could simplify widespread tuberculosis screening, especially in clinics with limited resources. That could enhance efforts to find and treat people with TB and help control global spread of the deadly infection.

In the study, researchers at the Yale School of Public Health (New Haven, CT, USA) examined the accuracy of a next-generation molecular testing cartridge called GeneXpert MTB/RIF Ultra (Xpert Ultra), made by Cepheid (Sunnyvale, CA, USA). Widely used worldwide, the test runs automatically to detect DNA from Mycobacterium tuberculosis, which causes TB. With a sputum sample, the test is nearly as sensitive as gold-standard culture techniques. How it might perform with saliva, though, had not been previously investigated.

The research team recruited clinic patients who were already known to have tuberculosis. Per routine, each participant first coughed up a sputum sample, with which the researchers confirmed infection by both culturing it and cartridge testing. Then, each provided saliva, which the team loaded into another Xpert Ultra cartridge. The results were encouraging. Among 78 people with culture-confirmed TB, the cartridges picked up 70 cases using saliva, which works out to 90% sensitivity.

Among people living with HIV, the test did less well, picking up just under three-fourths of known tuberculosis cases. By contrast, in HIV-negative people, it found 95% of cases. Because of their altered immune response, tuberculosis-affected people living with HIV tend to have fewer tuberculosis bacteria than their HIV-negative counterparts. The study was intentionally small, intended to get an idea of whether the method works. The researchers have not yet tried testing children’s saliva, nor that of people with non-productive cough - both groups that could benefit from saliva testing.

Evidence that the test might also work with saliva is welcome. Previous research has explored the use of saliva in TB diagnosis. But the current study is the largest of its kind, and the first to use a widely available testing device. Having demonstrated saliva testing is feasible, the researchers plan next to test larger groups, such as members of patients’ households. They also aim to see if procedural tweaks, like asking people not to eat or brush their teeth before providing a sample, might improve test performance.

“What we wanted to do in this study was to try to improve on the standard diagnostic technologies,” said senior author Dr. J. Lucian “Luke” Davis, MD, who is an associate professor of epidemiology (microbial diseases) at the Yale School of Public Health and of medicine (pulmonary) at the Yale School of Medicine. “We were able to meet that threshold in this project.”

Related Links:
Yale School of Public Health 
Cepheid


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.